Jane Street Group, LLC Halozyme Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $5.98 Million - $7.5 Million	116,500 New	116,500 $6.66 Million
Q1 2022 May 17, 2022	SELL	$31.97 - $41.06 $1.46 Million - $1.87 Million	-45,600 Reduced 60.96%	29,200 $1.16 Million
Q4 2021 Feb 15, 2022	BUY	$31.82 - $40.75 $1.23 Million - $1.57 Million	38,600 Added 106.63%	74,800 $3.01 Million
Q3 2021 Nov 16, 2021	SELL	$38.47 - $46.42 $630,908 - $761,288	-16,400 Reduced 31.18%	36,200 $1.47 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $1.64 Million - $2.16 Million	42,100 Added 400.95%	52,600 $2.39 Million
Q1 2021 May 18, 2021	SELL	$39.51 - $51.45 $1.99 Million - $2.59 Million	-50,300 Reduced 82.73%	10,500 $438,000
Q4 2020 Feb 17, 2021	BUY	$25.81 - $43.62 $178,089 - $300,978	6,900 Added 12.8%	60,800 $2.6 Million
Q3 2020 Nov 17, 2020	SELL	$25.74 - $29.63 $3.58 Million - $4.12 Million	-139,000 Reduced 72.06%	53,900 $1.42 Million
Q2 2020 Aug 17, 2020	BUY	$16.25 - $26.81 $2.97 Million - $4.9 Million	182,600 Added 1772.82%	192,900 $5.17 Million
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $143,170 - $224,848	10,300 New	10,300 $185,000
Q2 2019 Aug 15, 2019	SELL	$14.75 - $17.26 $147,500 - $172,600	-10,000 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$13.94 - $17.58 $144,976 - $182,831	-10,400 Reduced 50.98%	10,000 $161,000
Q4 2017 Feb 15, 2018	SELL	$16.75 - $20.8 $65,325 - $81,120	-3,900 Reduced 16.05%	20,400 $413,000
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $285,768 - $422,819	24,300	24,300 $422,000

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.66B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.